Targeting chronic inflammation to treat cognitive decline – interview with ADvantage Therapeutics QUADSMaster June 10, 2024
quadraScope to present at the 2024 Healthspan Summit Longevity Investment Panel QUADSMaster May 13, 2024
Solving DNA mutations central to aging and disease – interview with Chris Bradley QUADSMaster December 9, 2023
quadraScope presented two posters at the 2023 Biomarkers of Aging Symposium QUADSMaster December 6, 2023
Turn Bio receives positive feedback following an FDA INTERACT meeting to advance epigenetic reprogramming for skin rejuvenation into clinical trials QUADSMaster October 25, 2023